Respiratory Tract Diseases  >>  Alvesco (ciclesonide)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
NCT00367263: Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary

Completed
N/A
12
US
Alvesco (Ciclesonide) 160 ug/day
Allergy & Asthma Medical Group & Research Center
Asthma
 
11/06
ARTIST, NCT00608218: Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma

Completed
N/A
2100
Europe
Ciclesonide
AstraZeneca
Asthma
08/08
08/08
ATEM, NCT01147224: (Alvesco Non-interventional Study)

Completed
N/A
400
Europe
Alvesco, Ciclesonide
AstraZeneca
Asthma, Allergy
05/11
08/11
SISRIP, NCT01369563: Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis

Completed
N/A
1630
RoW
AstraZeneca
Perennial Rhinitis, Seasonal Rhinitis
05/12
05/12
NCT01438255: Observational Study on Efficacy of Alvesco(Ciclesonide) in Asthma Children and Adolescent in Real Practice

Completed
N/A
274
RoW
Handok Inc.
Asthma
07/12
 

Download Options